MedTrace Logo

Mobilization of Mesenchymal Stem Cells During Liver Transplantation

NCT02557724 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2018-10-16

No results posted yet for this study

Summary

To study if the administration of corticoid hinder or enhance the mobilization of Mesenchymal Stem Cells (MSCs) in the peripheral blood during liver transplantation and whether this affects the outcome with respect to graft versus host response.

Conditions

  • Liver Failure
  • Liver Neoplasm

Interventions

PROCEDURE

blood samples

liver transplant patients will have (5) 3cc blood samples drawn at specific time points.

PROCEDURE

blood samples

liver resection patients will have (3) 3cc. blood samples drawn at specific time points

Sponsors & Collaborators

  • Rutgers, The State University of New Jersey

    lead OTHER

Principal Investigators

  • Yuriy Gubenko, MD · Rutrgers/SUNJ

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02557724 on ClinicalTrials.gov